Bosh sahifaRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Yopilish kursi
7,33 $
Kunlik diapazon
6,72 $ - 7,33 $
Yillik diapazon
5,60 $ - 15,74 $
Bozor kapitalizatsiyasi
2,70 mlrd USD
Oʻrtacha hajm
16,39 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 26,08 mln | 147,62% |
Joriy xarajat | 37,76 mln | 29,31% |
Sof foyda | -95,84 mln | -3,04% |
Sof foyda marjasi | -367,46 | 58,39% |
Har bir ulushga tushum | -0,34 | 20,93% |
EBITDA | -91,16 mln | 0,89% |
Amaldagi soliq stavkasi | -0,17% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 427,65 mln | 10,41% |
Jami aktivlari | 726,50 mln | 15,17% |
Jami passivlari | 201,94 mln | 4,71% |
Umumiy kapital | 524,56 mln | — |
Tarqatilgan aksiyalar | 286,84 mln | — |
Narxi/balansdagi bahosi | 4,01 | — |
Aktivlardan daromad | -32,73% | — |
Kapitaldan daromad | -38,14% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -95,84 mln | -3,04% |
Operatsiyalardan naqd pul | -59,22 mln | 18,78% |
Sarmoyadan naqd pul | -4,56 mln | -1 214,70% |
Moliyadan naqd pul | 16,46 mln | -69,38% |
Naqd pulning sof oʻzgarishi | -46,92 mln | -139,19% |
Boʻsh pul | -16,60 mln | 70,89% |
Haqida
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering.
The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson. Wikipedia
Tashkil etilgan
2013
Sayt
Xodimlar soni
500
